In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital (BWH) has ...
More than half of adults are infected by cytomegalovirus (CMV) by age 40, according to the Centers For Disease Control and Prevention. Yet it's very likely that you've never heard of this virus that's ...
In a recent article published in the journal JAMA Network, researchers performed a randomized clinical trial (RCT) to demonstrate the noninferiority of letermovir vs. valganciclovir for prophylaxis of ...
Cytomegalovirus, or CMV, is a common infection in both adults and children. Clinical trials for several vaccines are currently underway to help prevent people from developing CMV. The Centers for ...
Fortress Biotech, Inc. and its subsidiary Helocyte, Inc. have initiated a Phase 2 clinical trial to assess the efficacy of the Triplex vaccine, designed to prevent cytomegalovirus (CMV) reactivation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results